Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
3.110
+0.810 (35.22%)
Oct 3, 2025, 3:35 PM EDT
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $148.91 million as of October 3, 2025. Its market cap has increased by 348.78% in one year.
Market Cap
148.91M
Enterprise Value
148.73M
Revenue
1.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.11
Market Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 148.91M, an increase of 650.02%. That is a compound annual growth rate of 26.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 148.91M | 127.20% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | 13.62M | 378.33% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 713.40M |
| Glass House Brands | 610.83M |
| Northwest Biotherapeutics | 378.06M |
| CytoDyn | 326.51M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 287.63M |
| Silence Therapeutics | 240.89M |